EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Obesity-driven adipokine signaling in breast cancer: mechanistic insights, therapeutic challenges, and opportunities for precision oncology

Vadakke Kunnumma Soonu, Praveen Kumar Shenoy, Valiyaparampil Gopi Deepak Roshan, Vipin Gopinath, Krishnan Sreejith

Journal of Pathology and Translational Medicine · 15.09.2026 · 60 (5) · 476-492

DOI: 10.4132/jptm.2026.06.30 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pathology and Translational Medicine, erschienen am 15.09.2026. Verfasst von Vadakke Kunnumma Soonu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Microbiology, Dr. Janaki Ammal Campus, Kannur University, Thalassery, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the leading cause of illness and death among women worldwide, with more than 2.3 million new cases diagnosed each year. The incidence and fatality rates are steadily increasing, notably in Asian countries. Obesity has been established as a major and growing risk factor for breast cancer progression. The World Health Organization reports that adult obesity rates have doubled since 1990. Obesity promotes tumor growth by inhibiting adipokine production and activating cancer-promoting pathways. In obese people, the microenvironment surrounding breast cancer cells is drastically altered. This is mostly due to the malfunctioning of adipocytes (fat cells) and macrophages. These defective cells' adipokines alter signaling pathways required for cancer cell proliferation, survival, and inflammation. This dysregulation has a significant role in tumor development, metastasis, and resistance to traditional cancer treatments, particularly in obese patients. This review highlights the role of adipokines in breast cancer, with a focus on disease progression, therapeutic challenges, and knowledge gaps. Clarifying how obesity alters tumor biology is key to advancing personalized and effective treatments for obese patients.

Schlagwörter

Stichwörter der Autor:innen

AdipokinesBreast neoplasmsObesity

Autor:innen und Institutionen

  • Department of Biotechnology and Microbiology, Dr. Janaki Ammal Campus, Kannur University, Thalassery, India.
  • Division of Medical Oncology, Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre, Thalassery, India.
  • Division of Genetics and Cytogenetics, Department of Clinical Laboratory Service and Translational Research, Malabar Cancer Centre, Thalassery, India.
  • Department of Biotechnology and Microbiology, Dr. Janaki Ammal Campus, Kannur University, Thalassery, India. sreejithkrishnan@hotmail.com.

Zitieren

APA

Soonu, V. K., Shenoy, P. K., Deepak Roshan, V. G., Gopinath, V., & Sreejith, K. (2026). Obesity-driven adipokine signaling in breast cancer: mechanistic insights, therapeutic challenges, and opportunities for precision oncology. Journal of Pathology and Translational Medicine, 60(5), 476-492. https://doi.org/10.4132/jptm.2026.06.30

Vancouver

Soonu VK, Shenoy PK, Deepak Roshan VG, Gopinath V, Sreejith K. Obesity-driven adipokine signaling in breast cancer: mechanistic insights, therapeutic challenges, and opportunities for precision oncology. Journal of Pathology and Translational Medicine. 2026;60(5):476-492. doi:10.4132/jptm.2026.06.30

BibTeX
@article{Soonu2026,
  author = {Soonu, Vadakke Kunnumma and Shenoy, Praveen Kumar and Deepak Roshan, Valiyaparampil Gopi and Gopinath, Vipin and Sreejith, Krishnan},
  title = {Obesity-driven adipokine signaling in breast cancer: mechanistic insights, therapeutic challenges, and opportunities for precision oncology},
  journal = {Journal of Pathology and Translational Medicine},
  year = {2026},
  volume = {60},
  number = {5},
  pages = {476--492},
  doi = {10.4132/jptm.2026.06.30}
}
Kostenlos starten →